Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 201 - 202 of 202 in total
Inbakicept is a dimeric human IL-15 receptor α (IL-15Rα) sushi domain/human IgG1 Fc fusion protein. It is one of the active ingredients in Anktiva, a combination product also containing nogapendekin alfa, where a single inbakicept is complexed with two nogapendekin alfa components. This combination product was approved by the FDA...
Investigational
Matched Description: … Calmette-Guérin (BCG) immunotherapy; however, NMIBC is associated with a risk of disease recurrence or ... treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or ... 75% of all bladder tumours, is commonly treated with transurethral resection of the bladder tumour and
Matched Categories: … Amino Acids, Peptides, and Proteins …
TNP-2092 is under investigation in clinical trial NCT03964493 (TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection).
Investigational
Matched Iupac: … 3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1(28 ... ),2,4,9,19,21,25(29),26-octaen-26-yl]methylidene}amino]piperidin-4-yl}(methyl)amino)cyclopropyl]pyrrolidin …
Matched Description: … TNP-2092 is under investigation in clinical trial NCT03964493 (TNP-2092 to Treat Acute Bacterial Skin and
Matched Categories: … Heterocyclic Compounds with 4 or More Rings …
Displaying drugs 201 - 202 of 202 in total